Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 593 results for "Victoza"

A Novo Nordisk diabetes drug may save lives, but Wall Street shrugs

What Is It About Novo Nordisk's Diabetes Drug That Makes It a ...

Sales of Novo Nordisk's ( NYSE:NVO ) Victoza exited March at a blistering $2.8 billion annual pace, and with its sales rate still growing by double digits, the drug's peak potential is anyone's guess. Why is Victoza so widely used, and what is ... Motley Fool, 4 days ago
Novo diabetes drug cuts heart risks..., 6 days ago

20 images for Victoza

AfricanSeer, 1 week ago
DataMonitor HealthCare, 5 days ago
Nasdaq, 1 week ago, 1 week ago, 1 week ago
American Journal of Managed Care, 1 week ago
Nasdaq, 1 week ago
diaTribe, 1 week ago
AfricanSeer, 1 week ago
SRN News, 1 week ago

Novo Nordisk: Victoza's Cardiovascular Victory

Novo Nordisk (NYSE: NVO ) just released a very positive cardiovascular outcomes trial result for their type-2 diabetes medication Victoza (liraglutide) but the market responded with a 5% drop in Novo's share price. Why? I believe the answer is a ...
 Seeking Alpha1 week ago Novo Slumps As Leader Looks More Like A Follower  Seeking Alpha1 week ago Novo Nordisk (NVO) Reports Positive Trial Results on Victoza  Nasdaq1 week ago Diabetes Drug LixiLan Shows Positive Results for Phase 3 Trials  MedIndia1 week ago

Pending EC decision: Victoza, liraglutide, Opinion date: 28-Apr-2016

the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change to the terms of the marketing authorisation for the medicinal product Victoza. The marketing authorisation holder for this medicinal product ...
 European Medicines Agency1 month ago Novo Nordisk Receives Positive CHMP Opinion for Extended Victoza Indication  FirstWord Pharma1 month ago News and press releases: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 25-28 April 2016  European Medicines Agency1 month ago

Human medicines European public assessment report (EPAR): Victoza, liraglutide, Revision: 14, Authorised

This is a summary of the European public assessment report (EPAR) for Victoza. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and ...
 European Medicines Agency2 months ago

treatment with liraglutide reduces the risk of heart attack and stroke in patients with type 2 diabetes

A long-term outcomes trial found that, compared to placebo, use of the diabetes medication liraglutide (Victoza) is associated with lower rates of nonfatal stroke, nonfatal myocardial infarction, and cardiovascular death. Investigators randomized ...
 HCPLive1 day ago ADA 2016: Data from LEADER will allow Victoza to compete directly with Jardiance in type 2 diabetes patients with high CV risk  DataMonitor HealthCare5 days ago LEADER trial suggests CV benefits with Victoza  Drug Discovery News1 week ago Liraglutide Cuts CV Events in High-Risk Type 2 Diabetes Patients  Renal & Urology News1 week ago

Novo Nordisk A/S 1Q 2016 -- Forecast

=== Sales: -NovoRapid/ 1st Quarter -Total -Victoza -Levemir NovoLog AVERAGE 26,975 4,589 4,400 4,998 Prev. Year 25,200 3,957 ...
 Morningstar.com1 month ago ADRs End Lower; Novo Nordisk Falls  4 Traders1 week ago NOVO NORDISK A/S : Trims Guidance on Currency Rates  4 Traders1 month ago Novo Nordisk Trims Guidance on Currency Rates  Investors Hub1 month ago

Are Expensive Diabetes Drugs Worth It?

Thursday, June 23rd, 2016 15:24 (MedPage Today) -- Jardiance and Victoza improve hard outcomes, but at a hefty cost related news Cath Lab Recap: Hearts From Space; Renal Denervation Again; Mobile Cardiac Care Thursday, June 23rd, 2016 15:24 ...
 NewsFlow241 day ago
Forbes Middle East

This Diabetes Drug Saves Lives. You Can Thank The FDA

This evening, researchers are announcing that the diabetes drug Victoza prevents heart attacks, strokes and cardiovascular deaths. It is only the second diabetes drug ever to do so. And doctors and Novo Nordisk give credit to the new diabetes data ...
 Global Advisors1 week ago

Lilly fortifies its Trulicity case with new Lantus add-on data

Eli Lilly & Co. rolled out its weekly GLP-1 drug Trulicity in late 2014, looking to challenge Novo Nordisk's daily Victoza, which had dominated that market for years. But Lilly hasn't been resting on its weekly dosing alone. After all, it's also ...
 FiercePharma1 week ago
Monthly Prescribing Reference

New and Generic Drug Approvals: Victoza

Drug Name(s) VICTOZA FDA Application No. (NDA) 022341 Active Ingredient(s) LIRAGLUTIDE RECOMBINANT Company NOVO NORDISK INC Original Approval or Tentative Approval Date January 25, 2010 Chemical Type 1New molecular entity (NME) Review ...
 U.S. Food and Drug Administration1 month ago 6/6/16 - IDegLira receives unanimous 16-0 vote in favor of approval from FDA Advisory Committee  Pharmacy Choice2 weeks ago FDA Committee Votes in Favor of IDegLira  Monthly Prescribing Reference4 weeks ago Sanofi's Diabetes Drug Combination Wins FDA Panel Backing  Zacks.com4 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Victoza
Get updated on latest news & your favorite topics right in your inbox!
More     Less